A randomised, prospective double-blind, propiverine-controlled trial of imidafenacin in patients with overactive bladder.
about
Innovative pharmacotherapies for women with overactive bladder: where are we now and what is in the pipeline?Efficacy and safety of imidafenacin for overactive bladder in adult: a systematic review and meta-analysis.Delivery methods for drugs used in the treatment of overactive bladder.Comparison of mirabegron and imidafenacin for efficacy and safety in Japanese female patients with overactive bladder: A randomized controlled trial (COMFORT study).
P2860
A randomised, prospective double-blind, propiverine-controlled trial of imidafenacin in patients with overactive bladder.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
A randomised, prospective doub ...... ients with overactive bladder.
@en
A randomised, prospective doub ...... ients with overactive bladder.
@nl
type
label
A randomised, prospective doub ...... ients with overactive bladder.
@en
A randomised, prospective doub ...... ients with overactive bladder.
@nl
prefLabel
A randomised, prospective doub ...... ients with overactive bladder.
@en
A randomised, prospective doub ...... ients with overactive bladder.
@nl
P2093
P2860
P356
P1476
A randomised, prospective doub ...... ients with overactive bladder.
@en
P2093
P2860
P304
P356
10.1111/IJCP.12255
P577
2013-12-22T00:00:00Z